Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy
Clinical trial NCT03172598 · COMPLETED
Trial details
- NCT number
- NCT03172598
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-25
- Primary completion
- 2018-08-08
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.